Artificial Intelligence-Based Fluid Quantification in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Treated with Faricimab A real-life Study

被引:0
|
作者
Stanzel, Boris V. [1 ]
Messias, Andre Marcio [1 ]
Lorenz, Anna Theresa [1 ]
Darwisch, Warda [1 ]
Haring, Florian [1 ]
Roberts, Philipp K. [1 ]
Julich-Haertel, Henrike [1 ,2 ]
Boden, Karl Thomas [1 ]
Szurman, Peter [1 ,2 ]
机构
[1] Knappschafts Klinikum Saar GmbH, Krankenhaus Sulzbach, Eye Clin Sulzbach, Sulzbach, Saarland, Germany
[2] Klaus Heimann Eye Res Inst, Sulzbach, Germany
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
5642
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Artificial intelligence-based decision-making for age-related macular degeneration
    Hwang, De-Kuang
    Hsu, Chih-Chien
    Chang, Kao-Jung
    Chao, Daniel
    Sun, Chuan-Hu
    Jheng, Ying-Chun
    Yarmishyn, Aliaksandr A.
    Wu, Jau-Ching
    Tsai, Ching-Yao
    Wang, Mong-Lien
    Peng, Chi-Hsien
    Chien, Ke-Hung
    Kao, Chung-Lan
    Lin, Tai-Chi
    Woung, Lin-Chung
    Chen, Shih-Jen
    Chiou, Shih-Hwa
    THERANOSTICS, 2019, 9 (01): : 232 - 245
  • [32] Efficacy and Safety of Intravitreal Faricimab in Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Retinal Vein Occlusion: A Meta-Analysis
    Nichani, Prem A. H.
    Popovic, Marko M.
    Mihalache, Andrew
    Pathak, Ananya
    Muni, Rajeev H.
    Wong, David T. W.
    Kertes, Peter J.
    OPHTHALMOLOGICA, 2024,
  • [33] BUDGET IMPACT ANALYSIS OF FARICIMAB FOR TREATING PATIENTS WITH DIABETES MACULAR EDEMA OR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN PANAMA
    Hidalgo, J.
    Ordonez, J.
    Avlia, P.
    Munoz, J. M.
    VALUE IN HEALTH, 2023, 26 (06) : S93 - S93
  • [34] BUDGET IMPACT ANALYSIS OF FARICIMAB FOR TREATING PATIENTS WITH DIABETES MACULAR EDEMA OR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN GUATEMALA
    Hidalgo, J.
    Ordonez, J.
    Deutschmann, B.
    Arriola, A.
    Del Cid, J. M.
    Bustamante, W. Makepeace
    VALUE IN HEALTH, 2023, 26 (06) : S159 - S159
  • [35] RELATIVE EFFECTIVENESS OF FARICIMAB VS AFLIBERCEPT 8 MG AFTER LOADING PHASE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND DIABETIC MACULAR EDEMA
    Buhrer, C.
    Tabano, D.
    Cox, O.
    VALUE IN HEALTH, 2023, 26 (12) : S47 - S47
  • [36] The Real-World Efficacy and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study
    Aziz, Aamir Abdul
    Khan, Hannah
    Abbey, Ashkan Michael
    Almeida, David R. P.
    Avery, Robert L.
    Banda, Himanshu K.
    Barakat, Mark
    Bhandari, Ramanath
    Chang, Emmanuel Y.
    Haug, Sara
    London, Nikolas J. S.
    Sheth, Veeral
    Wolfe, Jeremy
    Singer, Michael Andrew
    Danzig, Carl J.
    Khanani, Arshad M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [37] Early real-world outcomes in patients with neovascular Age-related Macular Degeneration (nAMD) treated with Faricimab
    Raslan, Walid
    Younis, Saad
    Fabozzi, Lorenzo
    Hassan, Islam
    Palmieri, Filomena
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [38] The Role of Managed Care Professionals in the Management of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
    Kamal, Khalid M.
    AMERICAN JOURNAL OF MANAGED CARE, 2023, 29 (06): : S90 - S95
  • [39] A SYSTEMATIC LITERATURE REVIEW ON THE HUMANISTIC BURDEN OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND DIABETIC MACULAR EDEMA
    Pandey, R.
    Kim, E.
    Garmo, V
    Tabano, D.
    VALUE IN HEALTH, 2022, 25 (07) : S567 - S567
  • [40] Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment Aspects
    Justus G. Garweg
    Claudine A. Blum
    René-Pierre Copt
    Chiara M. Eandi
    Katja Hatz
    Christian F. Prünte
    Eleonora Seelig
    Gábor M. Somfai
    Ophthalmology and Therapy, 2023, 12 : 639 - 655